| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 481.51M | 353.34M | 560.72M | 389.75M | 274.22M |
| Gross Profit | 260.50M | 152.69M | 365.24M | 228.05M | 112.99M |
| EBITDA | 279.22M | 192.98M | 414.12M | 265.87M | 158.19M |
| Net Income | 193.67M | 90.17M | 307.45M | 172.44M | 71.94M |
Balance Sheet | |||||
| Total Assets | 1.87B | 1.78B | 1.84B | 1.71B | 1.61B |
| Cash, Cash Equivalents and Short-Term Investments | 327.41M | 316.88M | 294.04M | 148.80M | 236.76M |
| Total Debt | 709.12M | 712.98M | 797.34M | 816.09M | 670.96M |
| Total Liabilities | 732.70M | 732.55M | 814.12M | 835.07M | 687.21M |
| Stockholders Equity | 1.14B | 1.05B | 1.02B | 873.85M | 920.15M |
Cash Flow | |||||
| Free Cash Flow | 116.30M | 154.06M | 355.59M | 155.27M | 95.51M |
| Operating Cash Flow | 210.14M | 173.01M | 388.45M | 224.06M | 118.70M |
| Investing Cash Flow | -93.84M | -7.36M | -34.80M | -76.34M | 68.77M |
| Financing Cash Flow | -105.90M | -131.29M | -219.72M | -235.23M | -35.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | $2.45B | 5.74 | 21.40% | 3.72% | -2.29% | 31.43% | |
82 Outperform | $1.74B | 8.91 | 17.91% | 13.08% | 36.27% | 109.57% | |
78 Outperform | $137.16M | 2.10 | 14.03% | 5.08% | <0.01% | 28.26% | |
75 Outperform | $1.35B | 13.01 | 8.94% | 1.27% | -1.33% | 28.23% | |
71 Outperform | $1.58B | 21.19 | 10.36% | 12.31% | -4.20% | -26.95% | |
69 Neutral | $1.65B | 12.94 | 18.84% | 6.93% | 9.54% | 13.40% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |